New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export AZN’s income statement to Excel — free account
AstraZeneca PLC
AZNHealthcare Drug Manufacturers General
AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024.
- Revenue
- +6.70%
- EPS
- +23.5%
- Free cash flow
- +1.99%
- Total debt
- +1.75%
Quarter to September 2026, against a year earlier
175.62
0.17
+0.10%
Follow AZN
Alert me
What it owns vs. what it owes Q3 FY2026, Sep 30, 2026
It owes $23.2B more in debt than it holds in cash and short-term investments. Debt has risen from $27.8B to $31.4B since Q4 FY25. Shareholders’ equity is 43.2% of the balance sheet. What is a balance sheet?
Owns
$88.5BLong-term assets
$23.3BOther short-term assets
$8.2BCash & short-term investments
Funded by
$51.8BShareholders’ equity
$36.7BOther liabilities
$31.4BDebt
Debt is 26.2% of the total; shareholders’ equity 43.2%.
Net debt has held near 19% of assets since Q4 FY25.
Net debt ÷ assets (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Total assets | $114.1B | $114.0B | $115.8B | $119.9B |
| Net debt (debt less cash) | $22.0B | $24.3B | $24.4B | $23.2B |
| Net debt ÷ assets (right axis) | 19.3% | 21.3% | 21.1% | 19.4% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
8,186.00 | 5,044.00 | 7,703.00 | 5,831.00 |
+8 more quarters Free account |
Receivables |
16,379.00 | 15,989.00 | 15,165.00 | 16,335.00 | |
Inventory |
6,883.00 | 6,932.00 | 6,570.00 | 6,557.00 | |
Other current assets |
— | — | 175.00 | — | |
Total current assets |
31,448.00 | 27,965.00 | 29,613.00 | 28,723.00 | |
Property, Plant, Equpment (Net) |
14,064.00 | 13,615.00 | 13,121.00 | 12,962.00 | |
Long-Term Investments |
3,250.00 | 3,310.00 | 3,047.00 | 3,023.00 | |
Long-term receivables |
2,488.00 | 2,867.00 | 2,719.00 | 2,718.00 | |
Goodwill and Intangible Assets (Total) |
59,303.00 | 58,904.00 | 58,102.00 | 59,088.00 | |
Long Term Assets (Tax, Deferred) |
6,655.00 | 6,487.00 | 5,593.00 | 5,819.00 | |
Total non-current assets |
88,474.00 | 87,868.00 | 84,402.00 | 85,351.00 | |
Total Assets |
119,922.00 | 115,833.00 | 114,015.00 | 114,074.00 | |
Accounts Payable |
23,572.00 | 22,893.00 | 22,505.00 | 25,280.00 | |
Current Part of Debt |
4,949.00 | 5,808.00 | 7,576.00 | 3,104.00 | |
Current Part of Taxes to Pay |
1,621.00 | 1,468.00 | 1,299.00 | 1,084.00 | |
Other current liabilities |
680.00 | 958.00 | 807.00 | 767.00 | |
Total current liabilities |
31,267.00 | 31,553.00 | 32,570.00 | 30,617.00 | |
Long Term Debt (Total) |
26,465.00 | 23,683.00 | 24,454.00 | 24,715.00 | |
Pension and Post-Retirement Liabilities |
780.00 | 852.00 | 953.00 | 1,105.00 | |
Long Term Tax Liability (Deferred) |
3,617.00 | 3,463.00 | 3,471.00 | 3,500.00 | |
Non-current Liabilities (Other) |
3,647.00 | 3,590.00 | 3,678.00 | 3,997.00 | |
Total non-current liabilities |
36,841.00 | 33,910.00 | 34,061.00 | 34,738.00 | |
Total liabilities |
68,108.00 | 65,463.00 | 66,631.00 | 65,355.00 | |
Additional Paid In Capital |
35,286.00 | 35,282.00 | 35,275.00 | 35,266.00 | |
Common Stock (Net) |
388.00 | 388.00 | 388.00 | 388.00 | |
Retained Earnings |
14,069.00 | 12,592.00 | 9,672.00 | 10,972.00 | |
Shareholders Equity (Other) |
1,985.00 | 2,033.00 | 1,998.00 | 2,041.00 | |
Common Equity (Total) |
51,814.00 | 50,370.00 | 47,384.00 | 48,719.00 | |
Shareholders Equity (Total) |
51,814.00 | 50,370.00 | 47,384.00 | 48,719.00 | |
Shareholders Equity and Liabilities (Total) |
119,922.00 | 115,833.00 | 114,015.00 | 114,074.00 | |
Shares (Common) |
— | — | 1,549.00 | 1,550.00 | |
Shareholders Equity (Tangible) |
(7,489.00) | (8,534.00) | (10,718.00) | (10,369.00) | |
Net Debt |
23,228.00 | 24,447.00 | 24,327.00 | 21,988.00 | |
Total Debt |
31,414.00 | 29,491.00 | 32,030.00 | 27,819.00 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026